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Background: Rickets can occur due to Vitamin D deficiency or defects in its metabolism. Three rare genetic types
of rickets with different alterations of genes have been reported, including: Vitamin D dependent rickets type 1,
Vitamin D dependent rickets type 2 or also known as Vitamin D resistant rickets and 25 hydroxylase deficiency
rickets. Vitamin D dependent rickets type 1 is inherited in an autosomal recessive pattern, and is caused by
mutations in the CYP27B1 gene encoding the 1α-hydroxylase enzyme. We report here a new mutation in CYP27B1,
which lead to Vitamin D dependent rickets type 1.
Case presentation: We report on a 13-month-old Arabic Saudi girl with Vitamin D dependent rickets type 1 presented
with multiple fractures and classic features of rickets. A whole exome sequencing identified a novel pathogenic missense
mutation (CYP27B1:Homozygous c.1510C > T(p.Q504X)) which results in a protein truncating alteration. Both parents are
heterozygous carriers of the mutation. Based on data search in Human Gene Mutation Database, 63 CYP27B1 alterations
were reported: only 28.6% are protein truncating (5 nonsense, 13 frameshift insertions/deletions, 0 gross deletions), while
61.9% are non-truncating (38 missense, 1 small in-frame insertions/deletion), and 9.5% are possible protein-truncating
(5 splice, 1 regulatory).
Conclusion: The deleterious effect of this alteration, which was the only mutation detected in the CYP27B1 common
gene of Vitamin D dependent rickets type 1 in the proband, and its autosomal recessive inheritance fashion, both
support a pathogenic nature of this mutation as the cause of Vitamin D dependent rickets type 1.
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Vitamin D, whether synthesized in the skin or obtained
from the diet, is biologically inert and requires activation
via two selective metabolic steps; the second of them is
rate-limiting and hormonally regulated (Figure 1). Both
of the steps are catalyzed by cytochrome P450 enzymes
to form the active secosteroid hormone 1,25 dihydroxy-
vitamin D3 (1,25(OH)2D3) [1,2].
Vitamin D deficiency remains the commonest cause of
rickets worldwide [3,4]. So far, apart from liver or renal* Correspondence: babikeramir@hotmail.com
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unless otherwise stated.diseases that may affect vitamin D metabolism, three rare
genetic errors of vitamin D metabolism that can cause
rickets have been described [3-6]. The first involves
1α-hydroxylase deficiency, also described as vitamin D
dependent rickets type 1 (VDDR-1). The second type in-
volves defective vitamin D receptor (VDR), resulting in
vitamin D resistant rickets (VDRR), also known as vitamin
D dependent rickets type II (VDDR II) [3]. More rare, 25
hydroxy vitamin D3 (25OHD3) deficiency have been re-
ported and linked to a selective mutation in CYP2R1 gene
that leads to 25-hydroxylase deficiency [4,5].
Children with VDDR-1 may present with hypotonia,
muscle weakness, joint pain and deformity, growth failure,
seizures, or fractures in early infancy [3]. We report a
13-month-old girl with VDDR-1 presented with multipleLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Bio-activation pathway of vitamin D.
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ings of rickets. An initial CYP27B1 gene analysis for com-
mon alterations was performed and showed no disease-
associated mutations in this patient. However, the whole
exome sequencing identified a novel pathogenic mu-
tation (CYP27B1: Homozygous c.1510C >T(p.Q504X)) in
our patient.
Case presentation
A 13-month-old Arabic Saudi girl, previously well, pre-
sented with multiple fractures as a result of minor trau-
mas. She was adequately exposed to sunlight and had
normal perinatal, developmental, and nutritional history.
She is the only child for first-cousins parents, with no
family history of similar problems or metabolic bone
disease. Examination revealed normal growth for age,
mildly reduced muscle tone, normal teeth, rachitic rosary,
Harrison’s sulcus, widening of the wrist and bowing de-
formity of distal arms and legs. Her head circumference
was on the 50th centile for age with a frontal bossing and
wide anterior fontanel. She had a swelling, secondary to
fracture, over her right clavicle. However, the rest of her
skin examination was normal and no other signs, which
might suggest physical abuse. Initial investigations showed:
low serum calcium and phosphorus, high serum parathy-
roid hormone (PTH), high serum alkaline phosphatase, a
normal serum 25OHD3 which was repeated two times,
and inappropriately low normal serum 1,25(OH)2D3 sug-
gesting 1α-hydroxylation defect (Table 1). Radiological
workup showed generalized osteopenia with multiple frac-
tures involving the right clavicle, right ulna, left proximal
ulna and tibia bones. Disorganization of the growth plate
was apparent with classic features of rickets (Figure 2).In the light of the above biochemical results and se-
vere radiological findings, genetic types of rickets were
suspected. Initially, CYP27B1 gene analysis was per-
formed only for the common mutations in exon 2 and 8
and it was negative. Unfortunately, the genetic laboratory,
where the common mutations of CYP27B1 gene tests
were tested, did not offer further analysis of the same
common gene. Alternatively, It was suggested to perform
mutations analysis for hypophosphataemic rickets but
this was clinically and biochemically irrelevant in this pa-
tient. With a high clinical suspicion of 1α-hydroxylation
defect, a whole exome sequencing test was performed in
another genetic lab, with a report of a likely diagnosis of
VDDR-1 (MIM-609506). The exome sequencing revealed
a novel pathogenic nonsense deleterious mutation in
the proband’s CYP27B1 gene (CYP27B1: Homozygous
c.1510C >T (p.Q504X)), with both parents found to be
heterozygous carriers of the mutation (Table 2).
Awaiting the genetic results, the patient required high
doses of 1α-hydroxyvitamin D and calcium supplements
to heal her bones and to return serum chemistries to
normal (Table 1).
Discussion
CYP27B1 gene is located on chromosome 12q13.3. It
encodes a member of the cytochrome P450 superfamily
of enzymes, which are monooxygenases that catalyze
many reactions involved in drug metabolism and synthe-
sis of cholesterol, steroids and other lipids. CYP27B1
gene encodes 1α-hydroxylase enzyme that is localized to
the inner mitochondrial membrane of renal cells; in
which it activates 25OHD3 to synthesise 1,25(OH)2D3,
which binds to vitamin D receptor and regulates calcium




[N = 75–250 nmol/L]
Serum 1,25(OH)2D3




[N = 2.25–2.75 mmol/L]
Serum Phosphorus
[N = 1.45–2.16 mmol/L]
Serum Alkaline phosphatase
[N = 175–476 IU/L]
Serum Magnesium
[N = 0.7–1.1 mmol/L]
At presentation 119.5 16 52.9 1.94 0.82 1682 0.7
Treatment: She was started with high-dose 1α-hydroxyvitamin D3 (2000 IU/day) and elemental calcium (61 mg/kg/day), it was gradually increased to 150 mg/kg/day with
monitoring of serum levels
1 month 99.9 - 54.9 1.90 0.86 2027 -
Treatment: Addition of oral phosphate supplements. She developed diarrhoea, so it was stopped after 1 week
2 months 99.3 - 55.4 1.6 0.90 1276 -
Treatment: Continued on 1α-hydroxyvitamin D3 (2000 IU/day) and high-dose of calcium supplements (up to 200 mg/kg/day)
3 months - - Initially 14.00 then
back to 21.36
2.06 1.02 1358 -
Treatment: Started to wean off 1α-hydroxyvitamin D3. The PTH went high again, so it was initial dose was resumed again (2000 IU/day).
6 months - - 21.41 2.19 1.41 503 -
9 months - - 0.97 2.44 1.94 233 -
Treatment: 1α-hydroxyvitamin D3 was weaned off gradually down to (1200 IU/day), with calcium supplements (100 mg/kg/day)
10 months - - 0.63 2.29 2.11 222 0.7
Treatment: Daily Doses settled on 1α-hydroxyvitamin D3 (800 IU/day) and Calcium supplements (80 mg/kg/day)





















Figure 2 X-ray images at time of presentation showing generalized osteopenia with altered texture (a & b). Humeral metaphysis shows
frying with more pronounced lucency (a), and ulnar/radial metaphysis shows frying and cupping of their outline (b) - (white arrows). The cortices
are indistinct with coarse fuzzy trabecuale (a & b). Fracture of right clavicle (a), and proximal shaft of the ulna (b) - (black arrows).
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Table 2 Familial co-segregation analysis of the proband
Gene(s) Filtering model Location of alteration Alteration Proband Mother Father
CYP27B1 Autosomal recessive 12q13.1-q13.3 c.1510C > T(p.Q504X) Homozygous Heterozygous Heterozygous
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alterations in this gene are inherited in autosomal reces-
sive pattern, and are in association with VDDR-1 [7].
In our patient, the clinical, biochemical and radio-
logical findings were all consistent with those of previ-
ously reported patients with CYP27B1 gene alterations
[3,8]. The first reported negative result of genetic muta-
tions suggestive of VDDR-1 was based on inadequate
examination, only for the common alterations in exons 2
and 8 of CYP27B1. This, beside the suggestion of further
testing for hypophosphataemic rickets by the genetic lab,
which was clinically irrelevant in our patient, both had
mislead the directions of choice for further genetic test-
ing. It would have been reasonable to perform a full ana-
lysis of the CYP27B1 gene alone for any other mutations
in the first place, which could have detect the novel mu-
tation in our patient, before proceeding for a whole ex-
ome sequencing in this patient. Nonetheless, genetic
analysis with full exome sequencing, bioinformatics ana-
lysis and filtering based on autosomal and X-linked
dominant and recessive inheritance models of the pro-
band, mother, and father revealed 53 genes (70 unique
alterations) (Table 3). Manual review to rule out sequen-
cing artefacts and polymorphisms along with the med-
ical interpretation to rule out genes lacking clinical
overlap with the patient’s evaluated phenotype resulted
in 25 genes (36 unique alterations) (Table 3).
Alterations with likely clinical relevance “candidate
genes” underwent co-segregation analysis, in which 1
candidate gene (1 alteration): (CYP27B1:HomozygousTable 3 Full exome-sequencing results of the patient






Autosomal dominant genes (alterations) 12(13) 2
Autosomal recessive genes (alterations) 41 (57) 32
X-linked recessive genes (alterations) 0(0) 0
X-linked dominant genes (alterations) 0(0) 0
Y-linked genes (alterations) N/A N
Total genes (alterations) 53(70) 34
*The candidate gene in this patient is CYP27B1 gene, which is located in chromoso
enzymes. The cytochrome P450 proteins are monooxygenases, which catalyze man
and other lipids. The protein encoded by this gene localizes to inner mitochondrial
This reaction synthesizes 1, 25 dihydroxyvitamin D3, which binds to vitamin D rece
biologically active vitamin D and plays a major role in calcium homeostasis. Mutatioc.1510C > T(p.Q504X)) was selected for further inves-
tigations. The familial co-segregation analysis sustained the
significance of the identified gene alteration, and revealed
an inheritance fashion of the mutation as both parents
were found to be heterozygous carriers of the alteration
(Table 2).
This identified novel CYP27B1 alteration displayed
a deleterious nature and it is the likely cause of our
patient’s clinical findings. This is implemented by: Firstly,
the premature protein truncation effect of the alter-
ation. The c.1510C > T(p.Q504X) alteration results from
a C to T nucleotide substitution at position 1510. This
changes an amino acid from a glutamine to a stop codon;
and premature stop codons are typically deleterious in
nature [9-11]. Secondly, the inconsistency of the alter-
ation type with the previously reported predominant
CYP27B1 alterations. Based on data search in the Human
Gene Mutation Database (HGMD), 63 CYP27B1 alter-
ations were reported: only 28.6% are protein truncating
(5 nonsense, 13 frameshift insertions/deletions, 0 gross
deletions), while 61.9% are non-truncating (38 missense,
1 small in-frame insertions/deletion), and 9.5% are pos-
sible protein-truncating (5 splice, 1 regulatory) [12].
Thirdly, the inheritance pattern of the detected alteration
in our patient is consistent with an autosomal recessive
fashion.
Conclusion
The deleterious nature of the reported novel CYP27B1:





tal Post-clinical associated review
Characterized Clinically novel Total
(2) 0(0) 1(1) 1(1) 0(0)
(45) 1(1) 23(34) 24(35) 1(1)
(0) 0(0) 0(0) 0(0) 0(0)
(0) 0(0) 0(0) 0(0) 0(0)
/A N/A N/A N/A N/A
(47) 1(1) 24(35) 25(36) 1*(1)
me 12q13.3 and encodes a member of the cytochrome P450 superfamily of
y reactions involved in drug metabolism and synthesis of cholesterol, steroids
membrane where it hydroxylates 25-hydroxyvitamin D3 at the 1 alpha position.
ptor and regulates calcium metabolism. Thus this enzyme regulates the level of
ns in this gene can result in vitamin D dependent rickets type 1.
Babiker et al. BMC Research Notes 2014, 7:783 Page 6 of 6
http://www.biomedcentral.com/1756-0500/7/783in our patient supports its classification as a pathogenic
mutation for VDDR-1.
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